Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Psychiatry Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Psychiatry Other
    Asenapine, Olanzapine Effective in Patients With Bipolar 1 Disorder: Presented at WCBP - (DGDispatch)
    FDA: Boxed Warning Required for Varenicline, Buproprion Due to Risk of Suicidal Behaviour - (DGNews)
    Quetiapine Monotherapy Shows Potential in Post-Traumatic Stress Disorder: Presented at WCBP - (DGDispatch)
    Olanzapine Effective for Bipolar Disorder in Naturalistic Setting: Presented at WCBP - (DGDispatch)
    Study Suggests Irritability Should Be Considered When Diagnosing Bipolar Disorder in Children - (DGNews)

    News archive

     Recent webcasts/CME - Psychiatry Other
      A Guide to Advances in Pain Management: A Synopsis of Roundtable Discussions
      Recognizing and Managing Psychotic and Mood Disorders in Primary Care
      Challenges of the Comorbid Patient: Evaluating Common Comorbidities in Adults and Children/Adolescents and Treatment Considerations
      Mixed States: Practical Application of Evidence, Guidelines, and Clinical Judgment
      Hypomania: The Clinical Reality of Diagnosing Adult and Child/Adolescent Patients

      Webcasts/CME archive

       Recent cases - Psychiatry Other
        Female Sexual Dysfunction as a Comorbid Illness
        11p Microdeletion Including WT1 but not PAX6, Presenting with Cataract, Mental Retardation, Genital Abnormalities and Seizures: Case Report
        Comorbidity of Asperger's Syndrome and Bipolar Disorder
        Psychiatric Disorder Associated with Vacuum-Assisted Breast Biopsy Clip Placement: A Case Report
        Treating Bipolar Disorder in Patients with Renal Failure Having Haemodialysis: Two Case Reports

        Cases archive
          




        my personal edition > psychiatry other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Drug Holidays May Adversely Impact Older Children With Attention Deficit Hyperactivity: Presented at AACAP

        By Jerry Ingram

        MIAMI BEACH, FL -- October 17, 2003 -- Older children treated with methylphenidate (Oros) for attention deficit hyperactivity disorder (ADHD) may be adversely affected by drug holidays, according to research presented here on October 16th at the 50th Anniversary Meeting of the American Academy of Child and Adolescent Psychiatry.

        "One of the most interesting findings in this study is that the kids who took drug holidays seemed to do less well in terms of their functioning at home as rated by parents than the kids who did not take the drug holidays, " said Stephen V. Faraone, PhD, lead researcher, Massachusetts General Hospital, Boston, Massachusetts. "To the contrary we found no decrease in efficacy according to teacher ratings and that's consistent with the fact that the drug holidays tend to be taken at home."

        For this study, investigators enrolled children between the ages of 6 and 13 years who were diagnosed with ADHD. The children were being treated with methylphenidate (Oros) as part of a multicenter, open-label, 12-month study.

        Drug holidays were assessed according to self-reported proportion of days that medication was not taken. Predictors of non-compliance with treatment were baseline demographic and clinical variable such as tic history, dose, ADHD subtype and Swanson, Nolan and Pelham Revision IV (SNAP-IV) questionnaire and IOWA Conners rating scale, parent/teacher efficacy ratings, and parent satisfaction.

        Researchers found that drug holidays were substantial and were predicted by baseline characteristics such as older age (P=0.02), inattentive subtype ADHD (P=0.0024), and fewer hyperactivity/impulsivity and oppositional defiant disorder symptoms (P<0.05). Lower methylphenidate dose and minority ethnic status also were predictive characteristics (P=0.03 and P=0.004, respectively).

        The researchers also noted that drug holidays during follow-up were associated with poorer efficacy at home (P=0.0016) but not at school (P=0.58).

        In light of the findings, they recommended caution when considering drug holidays for older ADHD children taking methylphenidate.


        [Study title: Drug Holiday Effects On ADHD Children Treated With Oros Methylphenidate. Abstract B15]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send